Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Endocr Pract. 2011 Sep 1;17(5):753–758. doi: 10.4158/EP11027.OR

Table 1.

Patient Characteristics

Total
N=82
50%
N=28
65%
N=29
80%
N=25
P-value
African American* 6 (7.3%) 1 (3.6%) 3 (10.3%) 2 (8.0%) 0.66
White American 76 (93%) 27 (96%) 26 (90%) 23 (92%)
Female 17 (21%) 5 (18%) 4 (14%) 8 (32%) 0.23
Age (years) 59 (8.4) 58 (8.0) 57 (9.1) 61 (7.5) 0.13
BMI (kg/m2) 33.2 (6.9) 32.2 (7.9) 34.1 (7.0) 33.2 (5.6) 0.59
Time to extubation (days) 1.3 (0.78) 1.3 (0.76) 1.1 (0.44) 1.5 (1.1) 0.30
Days on pressors 1.1 (0.80) 0.82 (0.61) 1.2 (0.77) 1.2 (0.99) 0.15
Creatinine (mg/dl) 0.99 (0.44) 1.0 (0.41) 0.90 (0.25) 1.1 (0.6) 0.24
Insulin (admission) 28 (34%) 10 (36%) 10 (35%) 9 (32%) 0.96
Any glucose-lowering drug (admission) 56 (68%) 19 (68%) 18 (62%) 19 (76%) 0.55
Indication for surgery
 Coronary artery bypass surgery 54 (66%) 19 (68%) 18 (62%) 17 (68%) 0.87
 Valve 23 (28%) 10 (36%) 9 (31%) 4 (16%) 0.25
 Aneurysm/dissection 5 (6.1%) 1 (3.6%) 3 (10%) 1 (4%) 0.49
 Other 11 (13%) 4 (14%) 5 (17%) 2 (8%) 0.60
Coronary artery disease 61 (77%) 22 (79%) 20 (71%) 19 (83%) 0.62
Diabetes at admission 57 (70%) 19 (68%) 18 (62%) 20 (80%) 0.35
Retinopathy 3 (3.9%) 3 (11%) 0 0 0.05
Nephropathy 3 (3.8%) 2 (7.4%) 0 1 (4.2%) 0.35
Neuropathy 12 (15%) 4 (15%) 4 (14%) 4 (16%) 0.98
Hypertension 70 (86%) 25 (89%) 22 (79%) 23 (92%) 0.31
Hyperlipidemia 65 (82%) 23 (85%) 20 (74%) 22 (88%) 0.37

Data are presented as mean (standard deviation) or number (%).

*

The 65% and 80% groups were collapsed and compared to the 50% group using Fisher’s exact test for the race variable due to insufficient cell counts.